Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Big Books & Bold Ideas with Kerri Miller
Kerri Miller and Marcheta Fornoff

Limited COVID-19 vaccine supply raises bioethics, equity questions

A researcher at Protein Sciences works in a lab
A researcher at Protein Sciences works in a lab on March 12 in Meriden, Conn. The biotech company is currently researching a vaccine for COVID-19.
Jessica Hill | AP Photo file

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Vaccinations for COVID-19 began across the country Monday morning. However, there aren't enough doses for everyone who wants or needs the vaccine to be immunized right away.

The supply shortage and logistical concerns with transportation and storage raise important questions on how the vaccine should be distributed. Minnesota is expecting doses for about 183,400 people in the initial rollout, which will cover about 3 percent of the state’s nearly 5.7 million residents.

Across the country, your spot in line largely depends on the parameters set by the health department and governor in your state. MPR News host Kerri Miller spoke with a vaccine researcher and a bioethicist about the best practices and challenges of distributing vaccines in a global pandemic.

Guests: 

  • Dr. Greg Poland is director of the Vaccine Research Group at Mayo Clinic.

  • Arthur Caplan is the founding head of the Division of Medical Ethics at the NYU School of Medicine. 

Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS.